Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus H Heim

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Nature Communications|August 13, 2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responsesQian Chen, Mairene Coto-Llerena, Aleksei Suslov, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapyChristian M Lange, Zoltan Kutalik, Kenichi Morikawa, et al.
Communications Medicine|July 5, 2022
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case reportMarie-Anne Meier, Sandro Nuciforo, Mairene Coto-Llerena, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancerKatrin Friedbichler, Madeleine Themanns, Kristina M Mueller, et al.
Neoplasia (New York, N.Y.)|November 18, 2016
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro ModelsMariacarla Andreozzi, Cristina Quintavalle, David Benz, et al.
Journal of Virology|May 6, 2016
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease PathogenesisSimonetta Bandiera, Sophie Pernot, Hussein El Saghire, et al.
Neoplasia (New York, N.Y.)|May 22, 2020
Corrigendum to "HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models" [Neoplasia 18 (2016) 724-731]Mariacarla Andreozzi, Cristina Quintavalle, David Benz, et al.
Oncogenesis|July 17, 2021
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysisRuize Gao, David Buechel, Ravi K R Kalathur, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Nature Communications|August 13, 2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responsesQian Chen, Mairene Coto-Llerena, Aleksei Suslov, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapyChristian M Lange, Zoltan Kutalik, Kenichi Morikawa, et al.
Communications Medicine|July 5, 2022
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case reportMarie-Anne Meier, Sandro Nuciforo, Mairene Coto-Llerena, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancerKatrin Friedbichler, Madeleine Themanns, Kristina M Mueller, et al.
Neoplasia (New York, N.Y.)|November 18, 2016
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro ModelsMariacarla Andreozzi, Cristina Quintavalle, David Benz, et al.
Journal of Virology|May 6, 2016
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease PathogenesisSimonetta Bandiera, Sophie Pernot, Hussein El Saghire, et al.
Neoplasia (New York, N.Y.)|May 22, 2020
Corrigendum to "HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models" [Neoplasia 18 (2016) 724-731]Mariacarla Andreozzi, Cristina Quintavalle, David Benz, et al.
Oncogenesis|July 17, 2021
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysisRuize Gao, David Buechel, Ravi K R Kalathur, et al.
Pageof 15